SCHEMBL4856370

SCHEMBL4856370

COc1ccc(OC)c(C=CC(=O)c2ccccc2OCCN(C)C)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.62
PDE4B Q07343 1/20 0.62
PDE4C Q08493 1/20 0.62
PDE4D Q08499 1/20 0.62
ABCG2 Q9UNQ0 2/20 0.55
JUN P05412 1/20 0.52
NFKB1 P19838 1/20 0.52
MAPT P10636 4/20 0.51
KDM4E B2RXH2 2/20 0.50
LMNA P02545 2/20 0.50
ATM Q13315 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
KEAP1 Q14145 1/20 0.49
NFE2L2 Q16236 1/20 0.49
MEN1 O00255 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
KMT2A Q03164 1/20 0.49
GAA P10253 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4851312 0.95 PDE4A (0.61) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL4856367 0.88 MAPT (0.60) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL4856281 0.88 MAPT (0.60) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL4854910 0.88 MAPT (0.49) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL4849955 0.88 MAPT (0.49) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL7188088 0.85 PDE4A (0.80) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL7188081 0.85 PDE4A (0.80) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL4855130 0.84 ABCB1 (0.47) ABCG2MAPTKDM4ELMNASMN1; SMN2
SCHEMBL4853733 0.84 ABCG2 (0.54) ABCG2KDM4ELMNASMN1; SMN2KEAP1
SCHEMBL4849381 0.84 ABCG2 (0.54) ABCG2KDM4ELMNASMN1; SMN2KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed